These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis. Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180 [TBL] [Abstract][Full Text] [Related]
3. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever. Orenstein WA; Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328 [TBL] [Abstract][Full Text] [Related]
4. The novel adjuvant dmLT promotes dose sparing, mucosal immunity and longevity of antibody responses to the inactivated polio vaccine in a murine model. Norton EB; Bauer DL; Weldon WC; Oberste MS; Lawson LB; Clements JD Vaccine; 2015 Apr; 33(16):1909-15. PubMed ID: 25765967 [TBL] [Abstract][Full Text] [Related]
5. Decision analysis in planning for a polio outbreak in the United States. Jenkins PC; Modlin JF Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814 [TBL] [Abstract][Full Text] [Related]
6. Long-term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines. Xiao Y; Daniell H Vaccine; 2017 Sep; 35(40):5418-5425. PubMed ID: 28111147 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of Two Different Sequential Schedules of Inactivated Polio Vaccine Followed by Oral Polio Vaccine Versus Oral Polio Vaccine Alone in Healthy Infants in China. Li RC; Li CG; Wang HB; Luo HM; Li YP; Wang JF; Ying ZF; Yu WZ; Shu JD; Wen N; Vidor E J Pediatric Infect Dis Soc; 2016 Sep; 5(3):287-96. PubMed ID: 26407255 [TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of immunization with live attenuated and inactivated poliovirus vaccines. Ogra PL Ann N Y Acad Sci; 1995 May; 754():97-107. PubMed ID: 7625685 [TBL] [Abstract][Full Text] [Related]
9. Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis. Swartz TA; Handsher R; Manor Y; Stoeckel P; Barkay A; Mendelson E; Leventhal A Vaccine; 1998 Dec; 16(20):2090-5. PubMed ID: 9796069 [TBL] [Abstract][Full Text] [Related]
10. Lack of immune interference between inactivated polio vaccine and inactivated rotavirus vaccine co-administered by intramuscular injection in two animal species. Wang Y; Zade J; Moon SS; Weldon W; Pisal SS; Glass RI; Dhere RM; Jiang B Vaccine; 2019 Jan; 37(5):698-704. PubMed ID: 30626530 [TBL] [Abstract][Full Text] [Related]
11. Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016. Hampton LM; Farrell M; Ramirez-Gonzalez A; Menning L; Shendale S; Lewis I; Rubin J; Garon J; Harris J; Hyde T; Wassilak S; Patel M; Nandy R; Chang-Blanc D; MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(35):934-8. PubMed ID: 27606675 [TBL] [Abstract][Full Text] [Related]
12. Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine. Hotta C; Ogawa T; Shirasawa H Hum Vaccin Immunother; 2019; 15(5):1154-1159. PubMed ID: 30676843 [TBL] [Abstract][Full Text] [Related]
13. Polio endgame: the global introduction of inactivated polio vaccine. Patel M; Zipursky S; Orenstein W; Garon J; Zaffran M Expert Rev Vaccines; 2015 May; 14(5):749-62. PubMed ID: 25597843 [TBL] [Abstract][Full Text] [Related]
14. Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine. Brickley EB; Strauch CB; Wieland-Alter WF; Connor RI; Lin S; Weiner JA; Ackerman ME; Arita M; Oberste MS; Weldon WC; Sáez-Llorens X; Bandyopadhyay AS; Wright PF J Infect Dis; 2018 Jan; 217(3):371-380. PubMed ID: 29304199 [TBL] [Abstract][Full Text] [Related]
15. Oral polio vaccine response in the MAL-ED birth cohort study: Considerations for polio eradication strategies. Pan WK; Seidman JC; Ali A; Hoest C; Mason C; Mondal D; Knobler SL; Bessong P; Vaccine; 2019 Jan; 37(2):352-365. PubMed ID: 30442479 [TBL] [Abstract][Full Text] [Related]
17. Intranasal and sublingual delivery of inactivated polio vaccine. Kraan H; Soema P; Amorij JP; Kersten G Vaccine; 2017 May; 35(20):2647-2653. PubMed ID: 28400164 [TBL] [Abstract][Full Text] [Related]
18. Differences in Antigenic Structure of Inactivated Polio Vaccines Made From Sabin Live-Attenuated and Wild-Type Poliovirus Strains: Impact on Vaccine Potency Assays. Crawt L; Atkinson E; Tedcastle A; Pegg E; ; Minor P; Cooper G; Rigsby P; Martin J J Infect Dis; 2020 Feb; 221(4):544-552. PubMed ID: 30788503 [TBL] [Abstract][Full Text] [Related]
19. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus. Yang C; Shi H; Zhou J; Liang Y; Xu H Vaccine; 2009 Nov; 27(47):6558-63. PubMed ID: 19729087 [TBL] [Abstract][Full Text] [Related]
20. Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the Nanopatch™ Microprojection Array. Wan Y; Hickey JM; Bird C; Witham K; Fahey P; Forster A; Joshi SB; Volkin DB J Pharm Sci; 2018 Jun; 107(6):1540-1551. PubMed ID: 29421219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]